Zolat 200 mg tabl. #2
Manufacturer: Emzor Pharmaceutical Industries , Nigeria
Composition: albendazole 200.0 mg
What is the active ingredient in Zolat 200 mg caplets?
Answer: Albendazole, with 200 mg per caplet.
What is the chemical name of Albendazole?
Answer: Methyl [5-(propylthio)-1H-benzimidazol-2-yl] carbamate.
How does Albendazole work to treat parasitic infections?
Answer: Inhibits tubulin polymerization in parasites, disrupting their metabolism and causing death.
How is Albendazole absorbed and metabolized in the body?
Answer: Absorbed and completely metabolized. Main metabolite, sulfoxide, reaches peak plasma concentrations after 2.5 hours.
What is the usual dosage of Zolat 200 mg caplets for adults and children over 2 years old?
Answer: One 400 mg caplet or two 200 mg caplets as a single dose.
Can Zolat 200 mg caplets be chewed or crushed?
Answer: Yes, they can be chewed, swallowed, or crushed and mixed with food.
What is the usual dosage of Zolat 200 mg caplets for children between one and two years old?
Answer: Not specified. A 10 ml suspension dosage is mentioned for this age group.
What are some possible side effects of Zolat 200 mg?
Answer: Gastrointestinal discomfort, diarrhea, headache, dizziness, hypersensitivity reactions.
What is the recommended treatment if a person experiences an overdose of Zolat 200 mg?
Answer: Induce vomiting or perform gastric lavage. Administer supportive therapy as needed.
Is Zolat 200 mg safe for pregnant women?
Answer: No, contraindicated due to teratogenic and embryotoxic effects.
What precautions should women of childbearing age take when using Zolat 200 mg?
Answer: Initiate treatment during the first week of their menstrual cycle or after a negative pregnancy test.
What is the recommended storage temperature for Zolat 200 mg?
Answer: Store below 30°C and protect from light.
Where can I find more information about Zolat 200 mg?
Answer: Contact Emzor Pharmaceutical Industries Limited.
What is the website for Emzor Pharmaceutical Industries Limited?
Answer: www.emzorpharma.com
When was the last time this leaflet was revised?
Answer: August 2024.